May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Color Discrimination in Type 2 Diabetes Mellitus Patients With No Retinopathy
Author Affiliations & Notes
  • C.F. Santana
    Psicologia Experimental,
    Universidade de Sao Paulo, Sao Paulo, Brazil
  • M.F. Costa
    Psicologia Experimental,
    Universidade de Sao Paulo, Sao Paulo, Brazil
  • M. Lago
    Psicologia Experimental,
    Universidade de Sao Paulo, Sao Paulo, Brazil
  • M. Bernick
    Hospital Universitario,
    Universidade de Sao Paulo, Sao Paulo, Brazil
  • M. Nishi
    Hospital Universitario,
    Universidade de Sao Paulo, Sao Paulo, Brazil
  • D.F. Ventura
    Psicologia Experimental,
    Universidade de Sao Paulo, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships  C.F. Santana, None; M.F. Costa, None; M. Lago, None; M. Bernick, None; M. Nishi, None; D.F. Ventura, None.
  • Footnotes
    Support  FAPESP, CAPES, CNPq
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4579. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C.F. Santana, M.F. Costa, M. Lago, M. Bernick, M. Nishi, D.F. Ventura; Color Discrimination in Type 2 Diabetes Mellitus Patients With No Retinopathy . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4579.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the color discrimination in type 2 diabetic (DM) patients by Farnsworth (D15), Lanthony (D15d) and Cambridge Color Test (CCT). Methods: The D15 and D15d tests were applied in 27 DM patients (mean=53.7 SD=10.6) and in 34 age–matched controls (mean=50.8 SD=13.5) with the specified illumination (103 lux provided by two fluorescent lamps Sylvania Octron 6500 K FO32W/65K). The CCT was performed in a subgroup of 21 DM patients and in 27 age–matched controls. We used the Trivector test, a short version used for rapid screening, and the Ellipses test which determine a MacAdam ellipse. All subjects had normal ophthalmologic examination and were tested monocularly. Results: DM results were worse for all Trivector confusion lines (protan, p=.008; deutan, p=.002; tritan, p<.001) and ellipse area (p=.032). The results for the D15 and D15d showed difference in comparison with controls, respectively, p=.022; p=.002. Moderate correlation was verified between the duration of DM and the D15 results (r= .48; p= .011) and D15d (r= .45; p= .017). A correlation between duration of DM and color vision loss was also found for the CCT results in the protan (r= .48; p= .028) and tritan (r= .60; p= .003) axes of the Trivector test and in the MacAdam ellipse area (r= .53; p= .015). Total number of patients with color vision losses was similar in the CCT (57%) and the D15d (60%). Both were correlated with the time of DM (CCT r= .70, p< .001; D15d r= .39, p= .044). Among the patients with color defect classification, the distribution of type of defect is very similar in both tests (CCT tritan= 58%, diffuse= 42%; D15d tritan= 56%, diffuse= 44%). Conclusions: About 60% of the non–retinopathic diabetic patients have color vision losses measured by the D15d and CCT. Most are tritan defects, but both the CCT and the D15d show that at least 40% of the losses may be diffuse.

Keywords: color vision • diabetes • clinical (human) or epidemiologic studies: risk factor assessment 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×